New methods of testing tissue and plasma beyond next-generation sequencing (NGS) could be used to deliver the best ...

The global next generation sequencing (NGS) market is expected to register a robust CAGR of around 15% over the next five years. This growth is primarily driven by the rising adoption of precision ...

Researchers at UW’s School of Medicine and the Institute for Research in Biomedicine Barcelona may have found an additional ...

Advances in next-generation sequencing (NGS) and synthetic DNA technologies are reshaping oncology research by enabling earlier cancer detection, more accurate biomarker discovery, and sensitive ...

Biomarker testing helps identify effective targeted therapies and avoid those that are less likely to work in certain ...

Oncology (cancer) diagnostics company NeoGenomics (NASDAQ:NEO) reported Q3 CY2025 results , with sales up 11.9% year on year ...

This insightful review explores key areas of cancer genetic research, focusing on genes that may benefit from ...

Across conversations on precision oncology, malignant hematology, cellular therapies, and social determinants of health (SDOH ...

"Fueled by advances in NGS and precision medicine, China’s DNA sequencing market sees rapid growth amid strong government support, rising clinical applications, and innovation hubs in Guangdong, ...